Ambitions for the US market
In an interview with The Japan Times, Minami Maeda, who became Rakuten Medical’s CEO in July, expressed high hopes for the technology the company has pursued for years.
We believe this could become a new platform for cancer treatment.
The United States is the world’s largest pharmaceutical market, and approval by US regulators would open access to a large patient population while strengthening the therapy’s scientific credibility worldwide.
How photoimmunotherapy works
Photoimmunotherapy combines a drug with light, based on the following basic principle:
- Patients receive a drug made of an antibody linked to a light-sensitive compound that binds to cancer cells.
- After a period of time, the tumour is illuminated with near-infrared red light.
- The light activates the compound, damaging the cancer cell membrane while sparing much of the surrounding healthy tissue.















